Clinical Screening of Acute Ruptures of the Anterior Cruciate Ligament of the Knee

NCT ID: NCT03113734

Last Updated: 2021-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

355 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-04-29

Study Completion Date

2021-08-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study develops the construction and validation of a reliable functional screening score in LCA ruptures in the immediate post-traumatic period.

This score, realizable in an emergency, would be an early warning signal requiring an emergency consultation with an orthopedic surgeon. It would be a tool for screening acute LCA ruptures at a time when ligament testing maneuvers are too painful to be contributory to the diagnosis. It would avoid a premature return to dangerous activity for the knee with a rupture of the LCA.

The other impact would be economical since it would avoid the realization of unnecessary MRI.

On the other hand, it will allow patients with LCA rupture to have faster access to MRI. The hypothesis of the study is that a validated functional score would make it possible to sort the patients in the emergencies and to prescribe the MRI only in the cases of effective rupture of the LCA.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A observational, Prospective, non-randomized, multi-centric study. The main objective of this study will be to determine the diagnostic performance (sensitivity and specificity) of a functional score for the detection of a rupture of the knee ACL in the immediate post-traumatic period.

It will follow the methodology for the evaluation of a new diagnostic test according to the STARD (Standards for Reporting of Diagnostic Accuracy) checklist.

Phases of the study

* Build score This phase will quantify the weight of each item and sub-items of the questionnaire already conceived from a statistical analysis adapted and thus to give a value to each item then a maximum value to the score.
* Validation of the score The score obtained will be validated in a different population versus MRI to determine its performance parameters. This score will be called the ACL-TS screening score (Tear Screening). An inter-evaluative reproducibility analysis of the score will be carried out in the investigative centers which have an emergency department
* Planned sample size For phase 1, a logistic regression will be performed. Empirically, there are 10 patients per variable for this questionnaire with 17 sub-items, 170 patients.

For Phase 2, the workforce was calculated on sensitivity because it is important to detect LCA ruptures. To obtain a sensitivity of 98% with a 2% CI, and taking into account a 10% rate of incomplete records, 210 patients should be included.

For the inter-evaluative ancillary reproducibility study, to obtain a Pearson coefficient of 0.8 (strong correlation if coefficient greater than 0.5) with a confidence interval of 0.67 to 0.88 and a risk of first 60 patients should be included.

Statistical analysis

* Analysis of normality of distributions
* Descriptive statistics: mean, standard deviation, minimum, maximum and median (quantitative variables); Frequency and percentage (qualitative variables).
* Comparisons of means: Student or Mann-Whitney according to the normality of the distributions
* Percentage comparisons: chi 2 or Fisher tests, idem
* The threshold of significance of the set of tests will be 0.05

Phase 1:

* A bi-varied study will then be carried out for each of the factors taken individually (search for an individual relationship, a rupture of the LCA confirmed by MRI vs the factors to be taken into account). These analyzes will provide an OR, an 95% CI of the OR, and a p-value measuring the severity of the association between the severe sprain and the factor taken into account.
* Follow a multivariate analysis (here logistic since the dependent variable will be "breaking ACL O / N"). To carry out this logistic regression, all factors for which p \<0.25 will be included in the model. A descending step-by-step method will arrive at the final model which will contain only those factors whose p will be less than 5% and whose 95% CI of the OR will not contain 1. Possibly it will be possible to adjust The model on certain parameters and to look for possible interactions. The ORs and IC95% obtained will allow the gravity scores to be established.

Phase 2:

* Performance parameters of the score with respect to the MRI: ROC curves with determination of the optimal threshold value, calculation of the area under the curve (AUC), Se, Sp, the likelihood ratios positive and negative and the proportion of Subjects.
* Identify the factors that can modify the sensitivity of the score (age, sex, sport level, laxity, meniscal or cartilage lesions) by bi-varied analyzes between the group correctly classified by the MRI and the score And on the other hand the group presenting a discrepancy between the reference examination and the score. If several factors are identified, these analyzes may be supplemented by a multivariate logistic regression analysis
* Pearson correlation coefficient and intra-class correlation coefficient to evaluate all correlations between quantitative variables (score reproducibility, differential score / laxity)
* Model the diagnostic approach including the score by developing a decision tree

Inclusion procedure The study will target 380 patients seen in an emergency. After a knee sprain, patients usually go to hospital or a treatment center for medical consultation. For the study, patients will be recruited either in the emergency department if the investigating center has an emergency department or in the corresponding medical-surgical centers of the investigating center. Investigating surgeons at the centers should inform physicians of the initiation of the study and the modalities of implementation.

Usually, patients are received by an emergency physician, orthopedic surgeon on duty or a sports physician. A standard radiographic assessment will be performed to eliminate the presence of a bone fracture. If the patient meets the test selection criteria, he / she will be informed of the study and his / her right to oppose the collection of his / her medical data. The patient will ask all the questions necessary for his understanding before confirming his non-opposition. The questionnaire will then be completed by the physician with the patient. In the centers where the reproducibility study will be carried out, a second doctor will complete the questionnaire.

Once the consultation has been completed, the physician will issue prescriptions for the usual medical treatment, laximetry prescription (GNRB) to be performed between 3 to 6 weeks after the accident when the knee is indolent and the prescription of the MRI to be performed between 7 days and 1 month after the accident. The physician will inform the patient that they should consult with the investigator's orthopedic surgeon once the results of GNRB and MRI are available within 6 weeks of the accident.

During this delayed consultation, the orthopedic surgeon will realize in this patient the dynamic maneuvers of ligament testing. The study will end there for the patient. The surgeon will then follow his usual diagnostic procedure to decide on the future care of the patient.

Ethical aspects Agreement will be sought from the local Ethics committee. All patients will be fully informed and will be provided with an information form. The data will be entered into an internet page and will be analysed anonymously.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Orthopedic Rupture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Construction and validation of a functional score

All patients will be treated at the same way:

Completion of questionnaire by the physician with him. Once the consultation has been completed, the physician will issue prescriptions for the usual medical treatment, laximetry prescription (GNRB) to be performed when the knee is indolent and the prescription of the MRI to be performed .The physician will inform the patient that they should consult with the investigator's orthopedic surgeon once the results of GNRB and MRI are available.The study will end there for the patient. The surgeon will then follow his usual diagnostic procedure to decide on the future care of the patient.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age of 18 to 55 years,
* Knee trauma occurred less than 9 days prior to hospital emergency visit or medical consultation,
* Absence of bone fractures on the standard radiographic assessment (face and profile),
* Patient affiliated to a social security scheme (beneficiary or beneficiary),
* Patient informed and confirmed his / her agreement to the study.

Exclusion Criteria

* Severe knee trauma requiring immediate surgical management (fractures, dislocations)
* Traumatic history (including sprain) on the same or other knee
* Impossibility or refusal to do an MRI
* Inability to understand information delivered
* Patient's refusal
* Patients can not be tracked for geographical reasons
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation Paul Bennetot

OTHER

Sponsor Role collaborator

Clinique les Maussins

UNKNOWN

Sponsor Role collaborator

Clinique Mutualiste de Lorient

UNKNOWN

Sponsor Role collaborator

French Arthroscopic Society

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Geoffroy NOURRISAT, PHD

Role: PRINCIPAL_INVESTIGATOR

Clinique des Maussins

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pr François-Xavier GUNEPIN

Lorient, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Ahlden M, Hoshino Y, Samuelsson K, Araujo P, Musahl V, Karlsson J. Dynamic knee laxity measurement devices. Knee Surg Sports Traumatol Arthrosc. 2012 Apr;20(4):621-32. doi: 10.1007/s00167-011-1848-7. Epub 2011 Dec 31.

Reference Type BACKGROUND
PMID: 22210516 (View on PubMed)

Bollen SR, Scott BW. Rupture of the anterior cruciate ligament--a quiet epidemic? Injury. 1996 Jul;27(6):407-9. doi: 10.1016/0020-1383(96)00033-2.

Reference Type BACKGROUND
PMID: 8881137 (View on PubMed)

Gunepin FX, Letartre R, Mouton C, Guillemot P, Common H, Thoreux P, Di Francia R, Graveleau N; Francophone Arthroscopy Society (SFA). Construction and validation of a functional diagnostic score in anterior cruciate ligament ruptures of the knee in the immediate post-traumatic period. Preliminary results of a multicenter prospective study. Orthop Traumatol Surg Res. 2023 Dec;109(8S):103686. doi: 10.1016/j.otsr.2023.103686. Epub 2023 Sep 28.

Reference Type DERIVED
PMID: 37776951 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SFA-ACL-TS 2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.